PETA US Welcomes Herbal Essences to Its Cruelty-Free Brand List
For Immediate Release:
21 February 2019
Jennifer White +44 (0) 20 7837 6327, ext 222; Je[email protected]
PETA US WELCOMES HERBAL ESSENCES TO ITS CRUELTY-FREE BRAND LIST
Iconic Procter & Gamble Brand Earns Spot on the ‘Beauty Without Bunnies’ List of Companies That Do Not Test on Animals
London – Procter & Gamble’s Herbal Essences brand has joined the PETA US “Beauty Without Bunnies” programme. The well-known brand has been added to the group’s list of companies and brands that don’t test on animals and will soon feature the cruelty-free bunny logo on its packaging.
The image is also available here.
Herbal Essences’ parent company, Procter & Gamble, has partnered with PETA US for many years to end animal testing in the beauty industry around the world, with notable changes made in regions such as China. The company is also collaborating with PETA US scientists on a variety of efforts to replace the use of animals in deadly toxicity testing. PETA US and Herbal Essences will continue to work together to ban animal testing globally.
“For years, we have been a pioneer in animal testing alternatives,” says Lisa Jennings, Vice President, Global Herbal Essences. “[PETA US’] cruelty-free credential and logo provide consumers with the assurance they are looking for as they choose their shampoos and conditioners. We’re proud to have passed [PETA US’] stringent verification process to join their trusted list of cruelty-free brands.”
“Procter & Gamble has shown a commitment to ending the use of animals in tests wherever and whenever possible and has worked for years to develop and promote non-animal methods,” says PETA US Senior Vice President Kathy Guillermo. “PETA US is pleased to collaborate with the company’s scientists to spare animals suffering in deadly tests, and we’re delighted to welcome Herbal Essences to our cruelty-free list.”
“Procter & Gamble’s work with the PETA International Science Consortium includes co-authoring a paper describing non-animal approaches to assess respiratory toxicity and participating in a consortium that works with the US Food & Drug Administration to gain regulatory acceptance for non-animal tests.”